115 related articles for article (PubMed ID: 36815785)
1. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
2. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
Day PM; Thompson CD; Lowy DR; Schiller JT
J Virol; 2017 May; 91(10):. PubMed ID: 28250129
[TBL] [Abstract][Full Text] [Related]
3. Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry.
Ishii Y; Nakahara T; Kataoka M; Kusumoto-Matsuo R; Mori S; Takeuchi T; Kukimoto I
PLoS One; 2013; 8(11):e80297. PubMed ID: 24244674
[TBL] [Abstract][Full Text] [Related]
4. Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates.
Pradini GW; Sahiratmadja E; Suhandono S; Sudigdoadi S; Yusuf M; Firdaus ARR; Susanto H
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2517-2523. PubMed ID: 32986347
[TBL] [Abstract][Full Text] [Related]
5. The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.
Lipovsky A; Erden A; Kanaya E; Zhang W; Crite M; Bradfield C; MacMicking J; DiMaio D; Schoggins JW; Iwasaki A
J Gen Virol; 2017 Nov; 98(11):2821-2836. PubMed ID: 29058661
[TBL] [Abstract][Full Text] [Related]
6. Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18.
Baidya S; Das R; Kabir MG; Arifuzzaman M
Bioinformation; 2017; 13(3):86-93. PubMed ID: 28584449
[TBL] [Abstract][Full Text] [Related]
7. The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein.
Dehghani B; Hasanshahi Z; Hashempour T; Motamedifar M
Biologia (Bratisl); 2020; 75(5):749-759. PubMed ID: 32435064
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring capsid protein variants L1 of human papillomavirus genotype 16 in Morocco.
El-Aliani A; Alaoui MAE; Chaoui I; Ennaji MM; Attaleb M; Mzibri ME
Bioinformation; 2017; 13(8):241-248. PubMed ID: 28959092
[TBL] [Abstract][Full Text] [Related]
9. A Peptide Derived from Sorting Nexin 1 Inhibits HPV16 Entry, Retrograde Trafficking, and L2 Membrane Spanning.
Li S; Williamson ZL; Christofferson MA; Jeevanandam A; Campos SK
bioRxiv; 2024 May; ():. PubMed ID: 38826391
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation.
Cumming SA; Cheun-Im T; Milligan SG; Graham SV
Biochem Soc Trans; 2008 Jun; 36(Pt 3):522-4. PubMed ID: 18481996
[TBL] [Abstract][Full Text] [Related]
11. The Micro-Immunotherapy Medicine 2LPAPI
Jacques C; Marchand F; Chatelais M; Albinet V; Coustal C; Floris I
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611099
[TBL] [Abstract][Full Text] [Related]
12. The BICD2 dynein cargo adaptor binds to the HPV16 L2 capsid protein and promotes HPV infection.
Speckhart K; Choi J; DiMaio D; Tsai B
PLoS Pathog; 2024 Jun; 20(6):e1012289. PubMed ID: 38829892
[TBL] [Abstract][Full Text] [Related]
13. Retromer stabilizes transient membrane insertion of L2 capsid protein during retrograde entry of human papillomavirus.
Xie J; Zhang P; Crite M; Lindsay CV; DiMaio D
Sci Adv; 2021 Jul; 7(27):. PubMed ID: 34193420
[TBL] [Abstract][Full Text] [Related]
14. Sequence-independent activity of a predicted long disordered segment of the human papillomavirus type 16 L2 capsid protein during virus entry.
Oh C; Buckley PM; Choi J; Hierro A; DiMaio D
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307721120. PubMed ID: 37819982
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2: the missing piece in the puzzle of pathogen-induced damage.
Li C; Yu J; Liao D; Su X; Yi X; Yang X; He J
Virulence; 2023 Dec; 14(1):2237222. PubMed ID: 37482693
[TBL] [Abstract][Full Text] [Related]
16. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y
J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
18. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
